AP-1 subunits: quarrel and harmony among siblings

被引:998
作者
Hess, J [1 ]
Angel, P [1 ]
Schorpp-Kistner, M [1 ]
机构
[1] Deutsch Krebsforschungszentrum, Div Signal Transduct & Growth Control, D-69120 Heidelberg, Germany
关键词
AP-1; transcription; subunits; Jun; Fos; ATF;
D O I
10.1242/jcs.01589
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The AP-1 transcription factor is mainly composed of Jun, Fos and ATF protein dimers. It mediates gene regulation in response to a plethora of physiological and pathological stimuli, including cytokines, growth factors, stress signals, bacterial and viral infections, as well as oncogenic stimuli. Studies in genetically modified mice and cells have highlighted a crucial role for AP-1 in a variety of cellular events involved in normal development or neoplastic transformation causing cancer. However, emerging evidence indicates that the contribution of AP-1 to determination of cell fates critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type and the cellular environment. Therefore, AP-1-mediated regulation of processes such as proliferation, differentiation, apoptosis and transformation should be considered within the context of a complex dynamic network of signalling pathways and other nuclear factors that respond simultaneously.
引用
收藏
页码:5965 / 5973
页数:9
相关论文
共 91 条
[21]   Signal transduction by the JNK group of MAP kinases [J].
Davis, RJ .
CELL, 2000, 103 (02) :239-252
[22]   C-FOS TRANSCRIPTIONAL ACTIVITY STIMULATED BY H-RAS-ACTIVATED PROTEIN-KINASE DISTINCT FROM JNK AND ERK [J].
DENG, TL ;
KARIN, M .
NATURE, 1994, 371 (6493) :171-175
[23]   AP-1: A double-edged sword in tumorigenesis [J].
Eferl, R ;
Wagner, EF .
NATURE REVIEWS CANCER, 2003, 3 (11) :859-868
[24]   Functions of c-jun in liver and heart development [J].
Eferl, R ;
Sibilia, M ;
Hilberg, F ;
Fuchsbichler, A ;
Kufferath, I ;
Guertl, B ;
Zenz, R ;
Wagner, EF ;
Zatloukal, K .
JOURNAL OF CELL BIOLOGY, 1999, 145 (05) :1049-1061
[25]   The Fos-related antigen Fra-1 is an activator of bone matrix formation [J].
Eferl, R ;
Hoebertz, A ;
Schilling, AF ;
Rath, M ;
Karreth, F ;
Kenner, L ;
Amling, M ;
Wagner, EF .
EMBO JOURNAL, 2004, 23 (14) :2789-2799
[26]   Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53 [J].
Eferl, R ;
Ricci, R ;
Kenner, L ;
Zenz, R ;
David, JP ;
Rath, M ;
Wagner, EF .
CELL, 2003, 112 (02) :181-192
[27]   A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs [J].
Eichhorst, ST ;
Müller, M ;
Li-Weber, M ;
Schulze-Bergkamen, H ;
Angel, P ;
Krammer, PH .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (20) :7826-7837
[28]  
Elkeles A, 1999, MOL CELL BIOL, V19, P2594
[29]   Fra-1 replaces c-Fos-dependent functions in mice [J].
Fleischmann, A ;
Hafezi, F ;
Elliott, C ;
Remé, CE ;
Rüther, U ;
Wagner, EF .
GENES & DEVELOPMENT, 2000, 14 (21) :2695-2700
[30]   Rhabdomyosarcoma development in mice lacking Trp53 and Fos:: Tumor suppression by the Fos protooncogene [J].
Fleischmann, A ;
Jochum, W ;
Eferl, R ;
Witowsky, J ;
Wagner, EF .
CANCER CELL, 2003, 4 (06) :477-482